---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-004178"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:39:45.691004+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision reports FY2023 revenue $442K; net loss ($70.6M) includes $60.9M goodwill impairment

## Summary
- Full-year 2023 revenue $442K vs $14K in 2022; Q4 revenue $128.8K vs zero in prior-year quarter.
- Net loss of ($70.6M) includes $60.9M one-time goodwill impairment; operating expenses $78.5M.
- Cash on hand $3.6M as of Dec 31, 2023; cash decreased $12.3M during the year.
- Clinical progress: VIVO European Registry enrolled 125 patients; LockeT initial trial >100 patients, second trial expected mid-2024.
- Intellectual property: 8 patent applications filed and 6 patents issued in 2023.

## SEC filing metadata
- accession: 0001654954-24-004178
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/0001654954-24-004178-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-004178
- JSON: https://secwatch.observer/filing/0001654954-24-004178.json
- Plain text: https://secwatch.observer/filing/0001654954-24-004178.txt

## Key facts
- Earnings Releases
  Catheter Precision, Inc. reported the quarter and year ended December 31, 2023 results: revenue $442 thousand, net income ($70.6) million.
  - Period: the quarter and year ended December 31, 2023
  - Revenue: $442 thousand
  - Net income: ($70.6) million
  - Result: reported results
  source text: Total revenues for the year ended December 31, 2023 were $442 thousand.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/0001654954-24-004178-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.